# Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes

> **NCT05403502** · NA · COMPLETED · sponsor: **Tandem Diabetes Care, Inc.** · enrollment: 183 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** t:slim X2 insulin pump with Control-IQ technology 1.5

## Key facts

- **NCT ID:** NCT05403502
- **Lead sponsor:** Tandem Diabetes Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-31
- **Primary completion:** 2023-08-02
- **Final completion:** 2023-08-02
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2024-07-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05403502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05403502, "Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05403502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*